AndroBioSys' Grant

AndroBioSys raised a round of funding on May 13, 2010. Investors include John R. Oishei Foundation.

AndroBioSys (ABS) is a biotech company focused on developing more effective treatments for prostate disease.…

Articles about AndroBioSys' Grant: